细胞毒性蛋白的肿瘤靶向递送研究进展
Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.
作者信息
Asrorov Akmal M, Gu Zeyun, Min Kyoung Ah, Shin Meong Cheol, Huang Yongzhuo
机构信息
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Institute of Bioorganic Chemistry, Academy of Sciences of Uzbekistan, 83, M. Ulughbek Street, Tashkent 100125, Uzbekistan.
出版信息
ACS Pharmacol Transl Sci. 2019 Dec 30;3(1):107-118. doi: 10.1021/acsptsci.9b00087. eCollection 2020 Feb 14.
Abstract
Great attention has been paid to cytotoxic proteins (e.g., ribosome-inactivating proteins, RIPs) possessing high anticancer activities; unlike small drugs, cytotoxic proteins can effectively retain inside the cells and avoid drug efflux mediated by multidrug resistance transporters due to the large-size effect. However, the clinical translation of these proteins is severely limited because of various biobarriers that hamper their effective delivery to tumor cells. Hence, in order to overcome these barriers, many smart drug delivery systems (DDS) have been developed. In this review, we will introduce two representative type I RIPs, trichosanthin (TCS) and gelonin (Gel), and overview the major biobarriers for protein-based cancer therapy. Finally, we outline advances on the development of smart DDS for effective delivery of these cytotoxic proteins for various applications in cancer treatment.
摘要
具有高抗癌活性的细胞毒性蛋白（例如，核糖体失活蛋白，RIPs）已受到极大关注；与小分子药物不同，由于其大尺寸效应，细胞毒性蛋白可有效保留在细胞内，并避免由多药耐药转运蛋白介导的药物外排。然而，由于各种生物屏障阻碍其有效递送至肿瘤细胞，这些蛋白的临床转化受到严重限制。因此，为了克服这些障碍，已开发出许多智能药物递送系统（DDS）。在本综述中，我们将介绍两种代表性的I型RIPs，天花粉蛋白（TCS）和相思子毒素（Gel），并概述基于蛋白质的癌症治疗的主要生物屏障。最后，我们概述了用于有效递送这些细胞毒性蛋白以用于癌症治疗中各种应用的智能DDS的开发进展。
相似文献
1
Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.细胞毒性蛋白的肿瘤靶向递送研究进展
ACS Pharmacol Transl Sci. 2019 Dec 30;3(1):107-118. doi: 10.1021/acsptsci.9b00087. eCollection 2020 Feb 14.
2
Toxic proteins application in cancer therapy.有毒蛋白在癌症治疗中的应用。
Mol Biol Rep. 2021 Apr;48(4):3827-3840. doi: 10.1007/s11033-021-06363-4. Epub 2021 Apr 25.
3
Studies on the anti-mitogenic, anti-phage and hypotensive effects of several ribosome inactivating proteins.几种核糖体失活蛋白的抗有丝分裂、抗噬菌体及降压作用的研究
Comp Biochem Physiol C Toxicol Pharmacol. 2001 Mar;128(3):359-66. doi: 10.1016/s1532-0456(00)00208-8.
4
Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis.纳米自组装共载姜黄素与阿苯达唑克服肿瘤多药耐药及转移
ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26648-26664. doi: 10.1021/acsami.7b05292. Epub 2017 Aug 3.
5
Improved Protein Toxin Delivery Based on ATTEMPTS Systems.基于 ATTEMPTS 系统的改良蛋白毒素递呈。
Curr Drug Targets. 2018 Feb 19;19(4):380-392. doi: 10.2174/1389450118666170302094758.
6
Genetically-engineered protein prodrug-like nanoconjugates for tumor-targeting biomimetic delivery via a SHEATH strategy.基于 SHEATH 策略的基因工程蛋白前药样纳米偶联物用于肿瘤靶向仿生递药。
Nanoscale. 2019 Jan 3;11(2):611-621. doi: 10.1039/c8nr08951e.
7
Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment.串联多聚体F3-去甲氧基鬼臼毒素融合毒素用于增强前列腺癌治疗的抗癌活性。
Int J Pharm. 2017 May 30;524(1-2):101-110. doi: 10.1016/j.ijpharm.2017.03.072. Epub 2017 Mar 27.
8
Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy.金葡菌肠毒素与抗胰岛素样生长因子-1 受体（IGF-1R）亲和肽的融合用于增强脑肿瘤治疗。
Arch Pharm Res. 2017 Sep;40(9):1094-1104. doi: 10.1007/s12272-017-0953-7. Epub 2017 Sep 12.
9
Recent progress in medicinal investigations on trichosanthin and other ribosome inactivating proteins from the plant genus Trichosanthes.近年来在药用研究中对天花粉和其他苦瓜属植物核糖体失活蛋白的研究进展。
Curr Med Chem. 2011;18(28):4410-7. doi: 10.2174/092986711797200499.
10
The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.植物核糖体失活蛋白丝瓜毒素和肥皂草素是HIV-1整合酶的有效抑制剂。
FEBS Lett. 2000 Apr 14;471(2-3):169-72. doi: 10.1016/s0014-5793(00)01389-2.
引用本文的文献
1
Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment.探索两种肿瘤治疗策略：核糖体失活蛋白和间充质干细胞/MSC衍生的细胞外囊泡在癌症治疗中的有效性。
Front Oncol. 2025 May 13;15:1533065. doi: 10.3389/fonc.2025.1533065. eCollection 2025.
2
Progressive cancer targeting by programmable aptamer-tethered nanostructures.通过可编程适配体连接的纳米结构对进展期癌症进行靶向治疗。
MedComm (2020). 2024 Oct 20;5(11):e775. doi: 10.1002/mco2.775. eCollection 2024 Nov.
3
Formulation, Characterization, and Potential Therapeutic Implications of Encapsulated Recombinant Alpha-luffin in Niosomes.脂质体包裹的重组α-丝瓜毒素的制剂、表征及潜在治疗意义
Curr Pharm Biotechnol. 2025;26(6):923-934. doi: 10.2174/0113892010316435240806053230.
4
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy.细菌纳米技术作为靶向癌症治疗递送和免疫治疗的一种范例。
Microsyst Nanoeng. 2024 Aug 20;10:113. doi: 10.1038/s41378-024-00743-z. eCollection 2024.
5
Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes.宿主和异源表达策略的重组毒素用于治疗目的。
Toxins (Basel). 2023 Dec 13;15(12):699. doi: 10.3390/toxins15120699.
6
Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein.ML1-STxB 融合蛋白的表达、纯化、鉴定及细胞毒性评价。
Arch Microbiol. 2023 May 6;205(6):220. doi: 10.1007/s00203-023-03563-3.
7
Polymer-Based mRNA Delivery Strategies for Advanced Therapies.基于聚合物的 mRNA 递呈策略用于先进疗法。
Adv Healthc Mater. 2023 Jun;12(15):e2202688. doi: 10.1002/adhm.202202688. Epub 2023 Feb 27.
8
MAPK Cascade Signaling Is Involved in α-MMC Induced Growth Inhibition of Multiple Myeloma MM.1S Cells via G2 Arrest and Mitochondrial-Pathway-Dependent Apoptosis In Vitro.丝裂原活化蛋白激酶（MAPK）级联信号通路通过G2期阻滞和线粒体途径依赖性凋亡参与α-多发性骨髓瘤细胞（α-MMC）诱导的多发性骨髓瘤MM.1S细胞生长抑制的体外研究。
Pharmaceuticals (Basel). 2023 Jan 13;16(1):124. doi: 10.3390/ph16010124.
9
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.细胞毒性酶作为抗癌药物的递呈进展。
Molecules. 2022 Jun 14;27(12):3836. doi: 10.3390/molecules27123836.
10
Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy.分子工程化的肿瘤酸度响应性植物毒素格列诺因用于安全有效的癌症治疗。
Bioact Mater. 2022 Feb 11;18:42-55. doi: 10.1016/j.bioactmat.2022.02.001. eCollection 2022 Dec.
本文引用的文献
1
Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems.纳米载体药物递送系统中使用的生物材料的吸收、分布、代谢和排泄。
Adv Drug Deliv Rev. 2019 Mar 15;143:97-114. doi: 10.1016/j.addr.2019.06.008. Epub 2019 Jun 28.
2
The extracellular matrix in tumor progression and metastasis.肿瘤进展和转移中的细胞外基质。
Clin Exp Metastasis. 2019 Jun;36(3):171-198. doi: 10.1007/s10585-019-09966-1. Epub 2019 Apr 11.
3
Genetically-engineered protein prodrug-like nanoconjugates for tumor-targeting biomimetic delivery via a SHEATH strategy.基于 SHEATH 策略的基因工程蛋白前药样纳米偶联物用于肿瘤靶向仿生递药。
Nanoscale. 2019 Jan 3;11(2):611-621. doi: 10.1039/c8nr08951e.
4
Role of Extracellular Matrix in Development and Cancer Progression.细胞外基质在发育和癌症进展中的作用。
Int J Mol Sci. 2018 Oct 4;19(10):3028. doi: 10.3390/ijms19103028.
5
Light-enhanced VEGF/rGel: A tumor targeted modality with vascular and immune-mediated efficacy.光增强 VEGF/rGel：一种具有血管靶向和免疫调节疗效的肿瘤治疗模式。
J Control Release. 2018 Oct 28;288:161-172. doi: 10.1016/j.jconrel.2018.09.005. Epub 2018 Sep 11.
6
Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy.氯毒素融合蓖麻毒素的基因工程与表征用于增强胶质母细胞瘤治疗。
J Drug Target. 2019 Nov;27(9):950-958. doi: 10.1080/1061186X.2018.1516221. Epub 2018 Sep 11.
7
Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.天花粉蛋白的结构与功能研究及其作为 I 型核糖体失活蛋白的药理机制。
Toxins (Basel). 2018 Aug 20;10(8):335. doi: 10.3390/toxins10080335.
8
Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.基于丝氨酸蛋白酶的靶向毒素提高临床实用性的策略。
Toxins (Basel). 2018 Feb 13;10(2):82. doi: 10.3390/toxins10020082.
9
Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy.用于癌症治疗的肝素调节前药型大分子诊疗系统
Nanotheranostics. 2017 Mar 3;1(1):114-130. doi: 10.7150/ntno.18292. eCollection 2017.
10
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.基于内含肽介导的定点连接构建的胶质瘤双重靶向纳米杂合蛋白毒素用于多阶段增强递药
Theranostics. 2017 Aug 15;7(14):3489-3503. doi: 10.7150/thno.20578. eCollection 2017.
Zotero 插件